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ABSTRACT
Von hippellindau(VHL)  disease being a rare genetic disorder, presents with broad spectrum of clinical manifestation 
and multiorgan neoplasms. The diagnostic criteria for VHL disease include  (i) one central nervous system 
haemangioblastoma and visceral manifestation , (ii) more than one central nervous system haemangioblastomas and 
(iii) known family history of VHL disease and any of the visceral manifestation. We report a case of 35 years-female 
patient who presented with recurrent cerebellar and spinal haemangioblastomas with new onset of retinal 
angioma,hepatichaemangioma and pancreatic cyst,  with previous history of surgical resection of cerebellar and spinal 
cord lesions. This report highlights the importance of imaging in  localizing multiple lesions in CNS and orbits, as these 
patients are difficult for surgical treatment, thus require gamma knife therapy (stereotactic radiosurgical ablation) and 
laser photocoagulation respectively.
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C A S E  R E P O R T
INTRODUCTION:
Von Hippel-Lindau (VHL) disease, an autosomal 
dominant disorder (1), is characterized by formation of 
both benign and malignant tumors in multiple organs 
with an incidence of one in 36,000 live births and more 
than  90% penetrance by the age of 65 years. 
Cross-sectional imaging including both contrast 
enhanced CT and MR scans plays pivotal role in the 
diagnosis of benign and malignant neoplasms in these 
patients, thus overall patient management. MRI is 
mainstay for detecting retinal, spinal, cerebral, and 
cerebellar lesions.
CASE REPORT:
We report a case of 35 year female patient who 
presented with severe occipital headache, lower limb 
paraparesis and ataxic gait in her peripartum period at 
the age of 27 years. She underwent MRI scan of brain 
and cervicodorsal spine which showed a well defined 
cystic lesion with enhancing solid component in 
cerebellar vermis and another similar lesion in dorsal 
spinal cord. She underwent surgical drainage of cystic 
component and excision of solid components, which on 
histopathology proved to be haemangioblastoma. Her 
elder sister also suffered from similar lesions and died 
at an early age. Our patient was diagnosed as Von 
Hippel Lindau disease, having two CNS lesions and 
positive family history. Her symptoms were mildly 
improved after surgical drainage and excision. Seven 
years later, she suffered from right sided gradual visual 
loss,for which she was referred to our department for 
MR scan of  brain and orbits . We included sections of 
cervicodorsal spine to assess possibility of recurrent 
lesions. Protocol for MR scan included T1 unenhanced 
and enhanced axial and sagital images, T2 and Coronal 
FLAIR sequences. 
MR brain showed recurrent cerebellar (Figure 1) and 
multilevel dorsal spine intradural as well as extradural 
haemangioblastomas (Figure 2).Few subcentimeter 
enhancing lesions were also indentified in bilateral 
cerebellar hemispheres (* in Figure 1). Moreover, right 
sided well defined enhancing T1 isontense intraocular 
lesion seen in continuity with the retina, representing 
retinal angioma/haemangioblastoma. ( Figure 1 and 
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Figure 3). 
Patient was referred to ophthalmologist for the 
management of retinal angioma and neurologist for 
further management.
Figure1: Axial T1 (a-b) and T2(c-d) sequences, 
demonstrates well defined T1 hyperintense and T2 
hypointense intraocular lesion (thin arrow) and cystic 
lesion with T1 isointense, T2 
heterogenoushyperintense peripheral solid nodule in 
cerebellar vermis(solid arrow).
Figure 2: Axial(a-b), coronal (d-e) and sagital (c and f) 
Post contrast images depicts Right intraocular lesion 
and solid  nodule of  cerebellar vermis lesion as 
described above  in figure 1 shows intense 
enhancement, along with subcentimeter enhancing 
lesions in bilateral cerebellar hemispheres (* in c).
Figure3: Multilevel well defined enhancing T1 
isointense lesions seen in dorsal spine.
DISCUSSION:
Von Hippel lindau disease or syndrome is a rare, 
inherited, autosomal dominant disorder, with a 
prevalence of 1 in 31,000 – 53000 , showing high 
penetrance and variable expression (2). This condition 
is caused by inactivation of tumor suppression gene on 
chromosome3p25.5 (3), which pertains the individuals 
at risk of developing benign and malignant neoplasms 
of multiple organs including  central nervous system, 
pancreas, adrenal glands, kidneys, adnexal and genital 
organs (4). 
There had been about 40 different lesions identified in 
14 different organs that includes central nervous 
system (CNS) and retinal hemangioblastomas, renal 
tumors or cysts, endolymphatic sac tumors, pancreatic 
tumors or cysts, pheochromocytomas and epididymal 
cystadenomas . The diagnostic criteria for VHL disease 
include  (i) one central nervous system 
haemangioblastoma and any visceral manifestation , 
(ii) more than one central nervous system 
haemangioblastomasand (iii) known family history of 
VHL disease and any of the visceral manifestation. 
Keeping in view the above criteria, if one or more 
cerebellar cystic lesion with solid enhancing nodule is 
identified in an adult patient, radiologist must suspect 
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the possibility of VHL and a search should be made to 
identify other lesions in retina or spine and  even 
visceral cysts and ask for family history. Similarly if a 
retinal lesion is identified , one should look for the 
associated lesions. Patients fulfilling any one of the 
criteria are labelled as VHL and therefore follow up 
imaging as well as family screening is highly 
recommended. The classical  triad of VHL is cerebellar 
haemangioblastoma, retinal angiomatosis and cysts of 
various organs (5).
As the disease is autosomal dominant, there is 50% 
chance of VHL inheritance from a carrier, with the 
incidence of new mutations being rare in 1 to 3 % 
cases (6). Therefore family members of VHL diagnosed 
patients are high risk gene carriers and their annual 
screening should be carried out both clinically and 
radiologically beginning from the age of 11(7).
Patients with VHL are categorized in  two types , on the 
basis of pheochromocytoma within the family: Type 1 
disease with low risk of pheochromocytoma is 
commoner than the type 2 disease which is with high 
risk of pheochromocytoma(6). Type 1 disease results 
from truncating mutations of VHL gene while Type 2 
disease results fromVHL missense mutations. Type 2 is 
further classified in 2A, 2B and 2C. Type 2A and type 
2B are based on the absence or presence of renal cell 
carcinoma respectively. Type 2C disease being rare is 
characterized by only development of 
pheochromocytomas(7).
Central nervous system haemangioblastomas are the 
most common manifestation , affect approximately 60 
to 80 percent of the patients. Retinal angiomas, also 
known as haemangioblastomas are also the most 
frequent manifestation of all known 40 diffferent types 
of lesions, which affects approximately 60 percent 
patients with VHL , are usually bilateral  and seen as 
first presentation in most cases. However in our patient 
, it was unilateral and seen later in the course of the 
disease. Endolymphatic sac tumors are seen in 10 to 
15 percent patients . Renal lesions varying from simple/ 
complex cystic lesions to clear cell renal carcinoma is 
found in 30 to 65 percent of patients.In VHL patients, 
renal cell carcinoma presents as complex cysts which 
on MR imaging show fluid intensity signals with 
enhancing mural nodules, enhancing walls and thick 
septations and T2 hypointense pseudocapsule.
Pheochromocytoma and extraadrenalparagangliomas 
affects around 10 to 20 percent of paients , and these 
could be the only manifestation in type 2C of VHL 
patients (7).On MR imaging, pheochromocytomas are 
iso- to hypointense to liver on T1 sequence , 
hyperintense on T2 sequence and marked 
enhancement during arterial phase of postcontrast 
dynamic imaging.
The other most common abdominal manifestations are 
multiple pancreatic cysts, affecting 50 to 90 percent of 
VHL patients, serous cystadenomas in 12 percent and 
neuroendocrine tumors in 5 to 17 percent. These may 
precede other manifestation and therefore if pancreatic 
lesion is identified , it assists in earlier recognition of 
VHL disease, management and genetic counseling (7). 
On MR imaging, simple pancreatic cysts appear 
hypointese on T1, hyperintense on T2 with no 
enhancement after contrast. Simple cysts are 
unilocular. Serous cystadenomas can be macrocystic or 
microcystic. Macrocystic cystadenomas are simple 
unilocular cysts with internal non enhancing thin 
septae. However microscystic cystadenomas are 
encapsulated fluid intensity lesion with multiple thin 
septae radially aligned, forming  multiple cysts of 
uniform size with honey comb appearance and internal 
central fibrous scar which is hypointense onT2 
sequence. On post contrast imaging, peripheral wall 
and internal septations show enhancement.
Scrotal lesions in male individuals are simple cysts and 
cystadenomas of epididymis. Cystadenoma is a rare 
entity and if bilateral then it is pathognomic for VHL 
disease (7). Ultrasound is modality of choice for 
identifying these cystic lesion in epididymis. On MR 
imaging, these appear hypointense on T1 , 
hyperintense on T2 with internal septate and mural 
nodules.
Pancreatic hemangiomas and hemangioblastomas, 
pulmonary hemangioblastomas, hepatic cysts and 
cavernous hemangiomas, splenic hemangiomas, 
bladder hemangioblastomas, cystadenomas of uterine 
broad ligament are other rare manifestations of VHL 
which are rarely reported and require substantial 
evidence for their association with VHL. There is limited 
literature available for these. However, they show 
similar histology and immunohistochemical properties 
as cerebellar haemangioblastomas.
Growth of haemangioblastoma is accelerated due to 
the haemodynamic and hormonal effects of pregnancy 
,  leading to pronounced clinical presentation in both 
mother and fetus (8). As in the above mentioned case 
report, patient was clinically silent before pregnancy , 
presented with exaggerated symptoms in her 
peripartum period with bilateral lower limb paraparesis.
If the lesions are detected at an early stage, they are 
managed accordingly with good prognosis which 
highlights the importance of annual screening. In case 
of cerebellar haemangioblastoma, the lesions less than 
3 cm are treated with gamma knife therapy. For the 
larger lesions, surgical resection is carried out. For 
retinal angiomas, the treatment of choice is 
cryotherapy as well as photocoagulation. Other options 
are vitrectomy and enucleation. 
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Jalbani et al. (9) presented the study of VHL disease in 
a Pakistani family comprising 6 members, who 
presented with VHL features in the period  of 13 years 
and on regular surveillance were diagnosed to have 
pheochromocytoma, which was subsequently treated 
and thus managed by multidisciplinary approach. This 
emphasizes the role of screening in these patients 
which plays major part in early detection, appropriate 
management in these patients, thus decreasing 
morbidity and mortality.
CONCLUSION:
Better understanding of the imaging appearances of 
broad spectrum and widespread lesions in VHL 
disease, challenges multidisciplinary approach for 
adequate patient management. This contributes in 
early diagnosis, genetic counseling of the symptomatic 
as well as asymptomatic family 
members,judiciomedical, surgical and radiological 
interventions which plays pivotal role in improving 
health, quality of life, reducing morbidity and mortality 
in these patients.
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